Literature DB >> 18786300

Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis.

Robert C Kern1, David B Conley, William Walsh, Rakesh Chandra, Atsushi Kato, Anju Tripathi-Peters, Leslie C Grammer, Robert P Schleimer.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) has been defined as persistent symptomatic inflammation of the nasal and sinus mucosa resulting from the interaction of multiple host and environmental factors. Recent studies have implicated Alternaria fungi or toxigenic Staphylococcus aureus as critical agents in CRS pathogenesis. The emphasis on environmental agents in CRS etiology has focused interest toward elimination of those agents as the prime mechanism of therapy. This viewpoint is in marked contrast to the current perspective on some other chronic inflammatory epithelial disorders that afflict the skin, lungs, and gut, wherein host factors are believed to predispose to disease expression in the presence of ubiquitous environmental agents.
METHODS: The current review evaluates CRS etiology from this perspective and considers that CRS develops, in part, as an outcome of a dysfunctional host response. Specifically, evidence from our laboratory and others will be reviewed indicating that CRS is associated with a failure of the mechanical and immunologic barriers across the nasal mucosa. The hypothesis would further propose that genetic and epigenetic variation predisposes susceptible individuals to barrier failure in the presence of environmental stress leading to CRS.
RESULTS: From this unifying perspective, bacteria and fungi are seen as disease modifiers rather than primary etiologic agents.
CONCLUSION: The goal is to place concepts of CRS pathophysiology in a framework consistent with a current understanding of chronic inflammation in general and epithelial disease in particular.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18786300      PMCID: PMC2802263          DOI: 10.2500/ajr.2008.22.3228

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  90 in total

Review 1.  Innate immunity in the mucosal immune system.

Authors:  Tomonori Nochi; Hiroshi Kiyono
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

2.  Proteases and Protease-activated receptors signalling: at the crossroads of acquired and innate immunity.

Authors:  Marc B Hershenson
Journal:  Clin Exp Allergy       Date:  2007-07       Impact factor: 5.018

3.  Involvement of Toll-like receptors in the immune response of nasal polyp epithelial cells.

Authors:  Jiyun Wang; Satoshi Matsukura; So Watanabe; Mitsuru Adachi; Harumi Suzaki
Journal:  Clin Immunol       Date:  2007-06-29       Impact factor: 3.969

4.  Protease-dependent activation of nasal polyp epithelial cells by airborne fungi leads to migration of eosinophils and neutrophils.

Authors:  Seung-Heon Shin; Young-Ho Lee; Chang-Ho Jeon
Journal:  Acta Otolaryngol       Date:  2006-12       Impact factor: 1.494

Review 5.  Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis.

Authors:  Murugappan Ramanathan; Andrew P Lane
Journal:  Otolaryngol Head Neck Surg       Date:  2007-03       Impact factor: 3.497

6.  A novel host defense system of airways is defective in cystic fibrosis.

Authors:  Patryk Moskwa; Daniel Lorentzen; Katherine J D A Excoffon; Joseph Zabner; Paul B McCray; William M Nauseef; Corinne Dupuy; Botond Bánfi
Journal:  Am J Respir Crit Care Med       Date:  2006-11-02       Impact factor: 21.405

7.  Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis.

Authors:  Fenna A Ebbens; Glenis K Scadding; Lydia Badia; Peter W Hellings; Mark Jorissen; Joaquim Mullol; Alda Cardesin; Claus Bachert; Thibaut P J van Zele; Marcel G W Dijkgraaf; Valerie Lund; Wytske J Fokkens
Journal:  J Allergy Clin Immunol       Date:  2006-11       Impact factor: 10.793

8.  A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.

Authors:  Geng Xu; Zhonglin Mou; Hongyan Jiang; Lei Cheng; Jianbo Shi; Rui Xu; Yun Oh; Huabin Li
Journal:  Laryngoscope       Date:  2007-05       Impact factor: 3.325

9.  Bacterial superantigens and T cell receptor beta-chain-bearing T cells in the immunopathogenesis of ulcerative colitis.

Authors:  N Shiobara; Y Suzuki; H Aoki; A Gotoh; Y Fujii; Y Hamada; S Suzuki; N Fukui; I Kurane; T Itoh; R Suzuki
Journal:  Clin Exp Immunol       Date:  2007-07-05       Impact factor: 4.330

10.  PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium.

Authors:  C Rudack; M Steinhoff; F Mooren; J Buddenkotte; K Becker; C von Eiff; F Sachse
Journal:  Clin Exp Allergy       Date:  2007-07       Impact factor: 5.018

View more
  101 in total

1.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

2.  Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Sarah Peterson; Julie A Poposki; Deepti R Nagarkar; Regina T Chustz; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Kathleen E Harris; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2011-09-23       Impact factor: 10.793

Review 3.  Immunopathology of chronic rhinosinusitis.

Authors:  Atsushi Kato
Journal:  Allergol Int       Date:  2015-02-09       Impact factor: 5.836

4.  Sinonasal T2R-mediated nitric oxide production in response to Bacillus cereus.

Authors:  Ryan M Carey; Alan D Workman; Carol H Yan; Bei Chen; Nithin D Adappa; James N Palmer; David W Kennedy; Robert J Lee; Noam A Cohen
Journal:  Am J Rhinol Allergy       Date:  2017-07-01       Impact factor: 2.467

5.  Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps.

Authors:  Julie A Poposki; Ashraf Uzzaman; Deepti R Nagarkar; Regina T Chustz; Anju T Peters; Lydia A Suh; Roderick Carter; James Norton; Kathleen E Harris; Leslie C Grammer; Bruce K Tan; Rakesh K Chandra; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2011-04-17       Impact factor: 10.793

Review 6.  Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis.

Authors:  David D Tieu; Robert C Kern; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2009-07       Impact factor: 10.793

7.  The significance of osteitis in rhinosinusitis.

Authors:  Neeraj Sethi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-27       Impact factor: 2.503

8.  Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.

Authors:  Cezmi A Akdis; Claus Bachert; Cemal Cingi; Mark S Dykewicz; Peter W Hellings; Robert M Naclerio; Robert P Schleimer; Dennis Ledford
Journal:  J Allergy Clin Immunol       Date:  2013-04-12       Impact factor: 10.793

Review 9.  Perspectives on the etiology of chronic rhinosinusitis.

Authors:  Bruce K Tan; Robert P Schleimer; Robert C Kern
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-02       Impact factor: 2.064

10.  Relationship between clinical measures and histopathologic findings in chronic rhinosinusitis.

Authors:  Zachary M Soler; David A Sauer; Jess Mace; Timothy L Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2009-10       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.